Author:
Shang Shun-Lai,Cai Guang-Yan,Duan Shu-wei,Li Ping,Li Qing-Gang,Chen Xiang-Mei
Funder
the National Key Technology R&D Program
the Fund of Chinese PLA 12th Five Year Plan for Medical Sciences
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. du Buf-Vereijken PW, Branten AJ, Wetzels JF. Idiopathic membranous nephropathy:outline and rationale of a treatment strategy [J]. Am J Kidney Dis. 2005;46(6):1012–29.
2. Hofstra JM, Wetzels JF. Management of patients with membranous nephropathy [J]. Nephrol Dial Transplant. 2012;27(1):6–9.
3. Hofstra JM, Wetzels JF. Alkylating agents in membranous nephropathy: efficacy proven beyond doubt [J]. Nephrol Dial Transplant. 2010;25(6):1760–6.
4. Radhakrishnan J, Cattran DC. The KDIGO practice guideline on glomerulonephritis: reading between the (guide) lines-application to the individual patient. Kidney Int. 2012;82(8):840–56.
5. Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am SocNePhrol. 2007;18(6):1899–904.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献